Theravance Biopharma Inc.

(TBPH) Trade

By |

Profile

Theravance Biopharma is a diversified biotechnology company that creates medicines to treat serious illnesses. The company's research and development are concentrated primarily on four therapeutic areas-infectious disease, respiratory, gastrointestinal disease, and cardiovascular and renal disease. Its commercial infrastructure is focused primarily on the acute care setting. The company uses strategic collaboration with other industry players. Theravance generates the majority of its revenue in the U.S. and Europe, followed by Asia.

Contact Information

Website: www.theravance.com
Email: investor.relations@theravance.com
Main Phone: +1 650 808-6000
Address: Ugland House, South Church Street
Address 2: George Town, PO Box 309
City / Town: Grand Cayman
Country: CYM
Postal Code: KY1-1104

Issuer Information

Exchange: NSD
CEO: Rick E. Winningham
Employees: 340
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 26.41 $ -0.68 (-2.51%)
Last Price 26.41 Change $ -0.68 Change % -2.51 Tick N/A
Bid 23.00 Bid Size 100.00 Ask N/A Ask Size 0.00
Open 26.80 High 27.15 Low 26.07 Prev Close 27.09
Last Trade Volume 285,838 52 Wk Hi 35.48 52 Wk Low 21.27
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 55,411,264.00 EPS (TTM) -4.73 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 30 72
Number of Buys 19 37
Number of Sells 11 35
Net Activity 186590 284148
Last 10 Buys Shares
Burton G. Malkiel 1,000
Frank Pasqualone 1,000
Henrietta Fore 1,000
Burton G. Malkiel 1,000
George M. Whitesides 1,000
Rick E. Winningham 1,000
Burton G. Malkiel 1,000
Junning Lee 1,000
Burton G. Malkiel 1,000
Rick E. Winningham 1,000
Last 10 Sell Shares
Bradford J. Shafer 1,000
Bradford J. Shafer 1,000
Renee D. Gala 1,000
Bradford J. Shafer 1,000
Brett K. Haumann 1,000
Brett K. Haumann 1,000
Bradford J. Shafer 1,000
Brett K. Haumann 1,000
Bradford J. Shafer 1,000
Brett K. Haumann 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 55 55 55 55
Low Target Price Estimate 22 22 22 22
Mean Target Price Estimate 37 37 37 37
Standard Deviation 13.28 13.28 13.28 13.28
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 3
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.14 2.14 2.14 2.33